Suchergebnisse - "Rustgi, Vinod"

PubPharm (24)

1

Daclatasvir and Peginterferon/Ribavirin for Black/African-American and Latino Patients with HCV infection

enthalten in: Annals of hepatology | 2016

von Rodriguez-Torres, M. | Lawitz, E. | Yangco, B. | +20

2

Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir Plus Dasabuvir With or Without Ribavirin in HCV-Infected Patients Taking Concomitant Acid-Reducing Agents

enthalten in: The American journal of gastroenterology | 2016

von Shiffman, M. | Rustgi, V. | Bennett, M. | +7

ErratumIn: Am J Gastroenterol. 2016 Jul;111(7):1077. - PMID 27356843

3

Daclatasvir + asunaprevir + beclabuvir ± ribavirin for chronic HCV genotype 1-infected treatment-naive patients

enthalten in: Liver international : official journal of the International Association for the Study of the Liver | 2016

von Everson, G. | Sims, K. | Thuluvath, P. | +17

CommentIn: Liver Int. 2016 Feb;36(2):181-4. - PMID 26781595

4

Ombitasvir/paritaprevir/r and dasabuvir plus ribavirin in HCV genotype 1-infected patients on methadone or buprenorphine

enthalten in: Journal of hepatology | 2015

von Lalezari, J. | Sullivan, J. | Varunok, P. | +9

5

Daclatasvir plus peginterferon alfa and ribavirin for treatment-naive chronic hepatitis C genotype 1 or 4 infection : a randomised study

enthalten in: Gut | 2015

von Hézode, C. | Hirschfield, G. | Ghesquiere, W. | +31

6

A randomized phase 2b study of peginterferon lambda-1a for the treatment of chronic HCV infection

enthalten in: Journal of hepatology | 2014

von Muir, A. | Arora, S. | Everson, G. | +122

7

Ledipasvir and sofosbuvir for 8 or 12 weeks for chronic HCV without cirrhosis

enthalten in: The New England journal of medicine | 2014

von Kowdley, K. | Gordon, S. | Reddy, K. | +82

CommentIn: Nat Rev Gastroenterol Hepatol. 2014 Jun;11(6):329. - PMID 24776807

8

Ledipasvir and sofosbuvir for untreated HCV genotype 1 infection

enthalten in: The New England journal of medicine | 2014

von Afdhal, N. | Zeuzem, S. | Kwo, P. | +121

CommentIn: Nat Rev Gastroenterol Hepatol. 2014 Jun;11(6):329. - PMID 24776807

9

Sofosbuvir for hepatitis C genotype 2 or 3 in patients without treatment options

enthalten in: The New England journal of medicine | 2013

von Jacobson, I. | Gordon, S. | Kowdley, K. | +76

CommentIn: N Engl J Med. 2013 May 16;368(20):1931-2. - PMID 23607592

10

Randomized study of asunaprevir plus pegylated interferon-α and ribavirin for previously untreated genotype 1 chronic hepatitis C

enthalten in: Antiviral therapy | 2013

von Bronowicki, J. | Pol, S. | Thuluvath, P. | +21